Creative Planning - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 195 filers reported holding ANIKA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 15.80 and the average weighting 0.0%.

Quarter-by-quarter ownership
Creative Planning ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$325,000
-5.2%
6,262
+0.1%
0.00%0.0%
Q3 2019$343,000
-44.4%
6,254
-58.8%
0.00%
-50.0%
Q2 2019$617,000
+34.1%
15,1980.0%0.00%0.0%
Q1 2019$460,000
-1.5%
15,198
+9.3%
0.00%0.0%
Q4 2018$467,000
+8.6%
13,908
+36.3%
0.00%0.0%
Q3 2018$430,000
+31.5%
10,2040.0%0.00%
+100.0%
Q2 2018$327,000
-35.6%
10,204
-0.1%
0.00%
-50.0%
Q1 2018$508,000
+14.4%
10,217
+24.2%
0.00%0.0%
Q4 2017$444,000
+788.0%
8,229
+719.6%
0.00%
Q2 2017$50,000
+8.7%
1,004
-4.7%
0.00%
Q1 2017$46,000
-6.1%
1,054
+5.0%
0.00%
Q4 2016$49,000
+2.1%
1,004
+0.4%
0.00%
Q3 2016$48,000
-17.2%
1,000
-7.9%
0.00%
Q2 2016$58,000
-13.4%
1,086
-27.6%
0.00%
-100.0%
Q1 2016$67,000
+34.0%
1,500
+15.4%
0.00%
Q4 2015$50,000
+56.2%
1,300
+30.0%
0.00%
Q3 2015$32,000
-22.0%
1,0000.0%0.00%
Q1 2015$41,0000.0%1,0000.0%0.00%
Q4 2014$41,000
+10.8%
1,000
-2.2%
0.00%
Q3 2014$37,000
-19.6%
1,022
+2.2%
0.00%
-100.0%
Q2 2014$46,000
+12.2%
1,0000.0%0.00%0.0%
Q1 2014$41,000
-18.0%
1,000
-23.1%
0.00%0.0%
Q4 2013$50,000
+16.3%
1,300
-28.5%
0.00%0.0%
Q3 2013$43,000
+152.9%
1,818
+81.8%
0.00%
Q2 2013$17,0001,0000.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Portolan Capital Management 217,105$10,058,0002.20%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 284,393$13,175,0000.88%
AMI ASSET MANAGEMENT CORP 183,494$8,501,0000.84%
CAPITAL MANAGEMENT CORP /VA 49,765$2,306,0000.74%
TFS CAPITAL LLC 105,839$4,904,0000.39%
Baltimore-Washington Financial Advisors, Inc. 24,390$1,130,0000.35%
OBERWEIS ASSET MANAGEMENT INC/ 27,600$1,279,0000.32%
Stephens Investment Management Group LLC 192,650$8,925,0000.27%
THOMPSON SIEGEL & WALMSLEY LLC 263,622$12,214,0000.24%
DIKER MANAGEMENT LLC 21,200$982,0000.22%
View complete list of ANIKA THERAPEUTICS INC shareholders